From: Biomaterials and tissue engineering for scar management in wound care
Materials | In vivo/vitro | Function | Ref | |
---|---|---|---|---|
Biomaterials composed of natural polymers | Hyaluronic acid (HA) in ECM | In vivo | Reducing TGF-β1 level in the wound, maintaining optimal viscoelastic properties of the ECM, and decreasing levels of fibronectin, fibromodulin, procollagen I, and HA synthase | |
Genipin cross-linked gelatin (GCG) and collagen sheets | In vivo | Scarless nerve regeneration, favorable nerve functional recovery | [35] | |
Microbial cellulose | In vivo | Improving the healing rate, decreasing pain and reducing scar tissue formation, necrotic debris removal, new cell migration and growth, and prompting reepithelialization | 36 | |
Collagen membrane cross-linked with glutaraldehyde | In vivo | Oral scar reducing, controlling infection in primary healing stage, and reducing growth of granulation tissue | [37] | |
Electrospun nanofibrous dressings composited of silk fibroin/gelatin and cellulose acetate | In vivo and in vitro | Increasing expression of vascular endothelial growth factor (VEGF) and existence of collagen type I | ||
Electrospun silk fibroin nanomatrix | In vivo | Reducing the wound healing period and scar formation | [40] | |
Biomaterials incorporated with bioactive molecules | Genipin-modified collagen sheets | In vivo | Reducing scars in first- and second-degree burns, assisting the synthesis of neodermal collagen matrices | |
Polyvinyl alcohol–sodium alginate gel-matrix-based wound dressing system containing nitrofurazone | In vivo | Keeping wound moist and prevent secondary damage, mild positive effects on inflammatory phase and create reducing wound size | [42] | |
Multifunctional acellular biologic scaffold | In vivo | Selective delivery and release of shielded biomaterials and bioactive substances, scaffolds help in vascularization, blood vessel formation, and keeps body temperature | [43] | |
Commercial calcium alginate | In vivo | Scarring prevention by moisture management and regulating amount of exudates in wound during the healing | [45] | |
Ginsenoside Rg3-loaded electrospun poly(lactic-co-glycolic acid) (PLGA) fibrous membranes | In vitro | Scar prevention, decreasing the expression of vascular endothelial growth factor (VEGF), mRNA, and collagen type I | [49] | |
Norfloxacin-loaded collagen/chitosan scaffold | In vivo | Controlling infection which contributes to lower inflammation, higher new cell growth, and faster wound closure | [50] | |
Dressing of polyester fabric containing elemental silver and zinc | In vivo | Promoting collagen synthesis and reepithelialization rate |